Ascentage Pharma Group International
Status: Publicly traded
Direct answer
Ascentage Pharma Group International is publicly traded on NASDAQ under the ticker AAPG.
Based in Suzhou, China, Ascentage Pharma Group International is a biotechnology firm primarily focused on clinical-stage development. The company is dedicated to discovering and advancing therapeutic solutions for a range of medical conditions, including various cancers, chronic hepatitis B virus (HBV) infections, and age-related ailments. A cornerstone of its product pipeline is HQP1351, a BCR-ABL inhibitor...
Can you invest in Ascentage Pharma Group International?
Yes. Ascentage Pharma Group International is publicly traded on NASDAQ under the ticker AAPG.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Ascentage Pharma Group International
Detailed equity research is provided by MarketSnap.